Institutional investors purchased a net $1.8 million shares of CYTR during the quarter ended March 2018. This may signal that the smart money is gaining interest in this company as the 16.65% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 2.0 Million shares of CytRx Corp
THE VANGUARD GROUP, INC. Bought 120.2 Thousand shares of CytRx Corp
DIMENSIONAL FUND ADVISORS LP Bought 25.7 Thousand shares of CytRx Corp